ClinicalTrials.gov
ClinicalTrials.gov Menu

GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00362687
Recruitment Status : Completed
First Posted : August 10, 2006
Last Update Posted : March 31, 2009
Sponsor:
Information provided by:
Gilead Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2008
  Actual Study Completion Date : October 2008